ZOGENIX, INC. | Business Contracts

First Supplemental Indenture, dated March 7, 2022, by and between Zogenix, Inc. and U.S. Bank Trust Company, National Association, as trustee (Filed With SEC on March 7, 2022)

Agreement and Plan of Merger, dated January 18, 2022, among UCB S.A., Zinc Merger Sub, Inc. and Zogenix, Inc (Filed With SEC on January 19, 2022)

Amendment to Employment Agreement, dated July 2, 2018 by and between the Registrant and Ashish Sagrolikar (Filed With SEC on November 8, 2021)

Collaboration, Option and License Agreement by and between Tevard Biosciences, Inc. and Zogenix, Inc (Filed With SEC on March 1, 2021)

Amendment No. 1 to Exclusive License Agreement by and between the Trustees of Columbia University and Modis Therapeutics, Inc., dated December 5, 2019 (Filed With SEC on March 2, 2020)

Description of Registered Securities (Filed With SEC on March 2, 2020)

Lease Agreement, dated October 1, 2018, by and between the Registrant and Emery Station West, LLC (Filed With SEC on February 28, 2019)

Second Amendment to Employment Agreement, dated July 2, 2018 by and between the Registrant and Ashish Sagrolikar (Filed With SEC on November 8, 2021)

Third Amendment to Employment Agreement, dated July 2, 2018 by and between the Registrant and Ashish Sagrolikar (Filed With SEC on November 8, 2021)

Independent Director Compensation Policy (Filed With SEC on August 5, 2021)

Zogenix, Inc. 2010 Equity Incentive Award Plan (as Amended and Restated effective May 27, 2021) (Filed With SEC on June 2, 2021)

Zogenix, Inc. 2021 Employment Inducement Equity Incentive Award Plan (Filed With SEC on June 2, 2021)

Indenture, dated as of September 28, 2020, between Zogenix, Inc. and U.S. Bank National Association, as trustee (Filed With SEC on September 28, 2020)

Employment Agreement dated April 20, 2020, by and between the Registrant and Shawnte M. Mitchell (Filed With SEC on August 6, 2020)

Underwriting Agreement, dated March 3, 2020, by and among Zogenix, Inc. and SVB Leerink LLC and Stifel, Nicolaus & Company, Incorporated, as representatives of the several... (Filed With SEC on March 4, 2020)

Form of Stock Option Grant Notice and Stock Option Agreement under the 2010 Equity Incentive Award Plan (Filed With SEC on March 2, 2020)

Supply Agreement, by and between the Registrant and Penn Pharmaceutical Services Limited, trading as PCI Pharma Services, dated July 17, 2019 (Filed With SEC on November 7, 2019)

Exclusive License Agreement by and between the Trustees of Columbia University and Modis Therapeutics, Inc. (as successor-in-interest to Meves Pharmaceuticals, LLC), dated... (Filed With SEC on November 7, 2019)

Agreement and Plan of Merger, dated August 23, 2019, by and among Zogenix, Inc., Xena Merger Sub, Inc., Modis Therapeutics, Inc. and Shareholder Representative Services, LLC, as... (Filed With SEC on August 26, 2019)

Zogenix, Inc. 2010 Equity Incentive Award Plan (Filed With SEC on May 22, 2019)

Manufacturing and Supply Agreement dated January 31, 2019 by and between Zogenix International Limited and Aptuit (Oxford) Limited (Filed With SEC on May 9, 2019)

Distributorship Agreement dated March 18, 2019 by and between the Registrant and Nippon Shinyaku Company, Ltd (Filed With SEC on May 9, 2019)

Lease Termination Agreement, dated October 1, 2018, by and between the Registrant and Emery Station Joint Venture, LLC (Filed With SEC on February 28, 2019)

ZOGENIX, INC. (23)